Russell A, Watts S
Department of Pharmacology and Toxicology, Michigan State University, East Lansing 48824-1317, USA.
J Pharmacol Exp Ther. 2000 Aug;294(2):598-604.
We characterized the thoracic aorta from the C57BL/6J mouse, a strain used commonly in the generation of genetically altered mice, in response to vasoactive substances. Strips of aorta were mounted in tissue baths for measurement of isometric contractile force. Cumulative concentration-response curves to agonists were generated to observe contraction, or relaxation in tissues contracted with phenylephrine or prostaglandin F(2alpha) (PGF(2alpha)). In endothelium-denuded strips, the order of agonist contractile potency (-log EC(50) [M]) was norepinephrine > phenylephrine = 5-hydroxytryptamine > dopamine > PGF(2alpha) > isoproterenol > KCl. Angiotensin II and endothelin-1 were weakly efficacious (15% of maximum phenylephrine contraction), as were UK14,304, clonidine, histamine, and adenosine. In endothelium-intact strips, agonists still caused contraction and both angiotensin II and endothelin-1 remained ineffective. In experiments focusing on angiotensin II, angiotensin II-induced contraction was abolished by the AT(1) receptor antagonist losartan (1 microM) but was not enhanced in the presence of the AT(2) receptor antagonist PD123319 (0.1 microM), tyrosine phosphatase inhibitor orthovanadate (1 microM) or when angiotensin II was given noncumulatively. Prazosin abolished isoproterenol-induced contraction and did not unmask isoproterenol-induced relaxation. Angiotensin II and endothelin-1 did not cause endothelium-dependent or -independent relaxation in phenylephrine- or PGF(2alpha)-contracted tissues. Acetylcholine but not histamine, dopamine, or adenosine caused an endothelium-dependent vascular relaxation. These experiments provide information as to the vascular reactivity of the normal mouse thoracic aorta and demonstrate that the mouse aorta differs substantially from rat aorta in response to isoproterenol, angiotensin II, endothelin-1, histamine, and adenosine.
我们对C57BL/6J小鼠的胸主动脉进行了表征,该品系常用于基因改造小鼠的培育,以研究其对血管活性物质的反应。将主动脉条安装在组织浴中以测量等长收缩力。生成激动剂的累积浓度-反应曲线以观察收缩情况,或观察在苯肾上腺素或前列腺素F(2α)(PGF(2α))收缩的组织中的舒张情况。在内皮剥脱的条带中,激动剂收缩效力的顺序(-log EC(50) [M])为去甲肾上腺素>苯肾上腺素 = 5-羟色胺>多巴胺>PGF(2α)>异丙肾上腺素>KCl。血管紧张素II和内皮素-1的效力较弱(为最大苯肾上腺素收缩的15%),UK14,304、可乐定、组胺和腺苷也是如此。在内皮完整的条带中,激动剂仍会引起收缩,而血管紧张素II和内皮素-1仍然无效。在针对血管紧张素II的实验中,血管紧张素II诱导的收缩被AT(1)受体拮抗剂氯沙坦(1 microM)消除,但在存在AT(2)受体拮抗剂PD123319(0.1 microM)、酪氨酸磷酸酶抑制剂原钒酸盐(1 microM)时并未增强,或者当非累积性给予血管紧张素II时也未增强。哌唑嗪消除了异丙肾上腺素诱导的收缩,且未揭示异丙肾上腺素诱导的舒张。血管紧张素II和内皮素-1在苯肾上腺素或PGF(2α)收缩的组织中未引起内皮依赖性或非内皮依赖性舒张。乙酰胆碱而非组胺、多巴胺或腺苷引起内皮依赖性血管舒张。这些实验提供了关于正常小鼠胸主动脉血管反应性的信息,并表明小鼠主动脉在对异丙肾上腺素、血管紧张素II、内皮素-1、组胺和腺苷的反应上与大鼠主动脉有很大不同。